Nephrotic Syndrome During Treatment with Interferon

Overview

Journal Br Med J (Clin Res Ed)

Specialty General Medicine

Date 1985 May 25

PMID 3924182

Citations 3

Authors

K Sriskandan

D E TEE

K W Pettingale

Affiliations

Soon will be listed here.

Citing Articles

Clinical toxicity of the interferons.

Vial T, Descotes J Drug Saf. 1994; 10(2):115-50.

PMID: 7516663 DOI: 10.2165/00002018-199410020-00003.

Preclinical safety testing of species-specific proteins produced with recombinant DNA-techniques. An attempt to transfer current experience into future testing strategies.

Teelmann K, Hohbach C, Lehmann H Arch Toxicol. 1986; 59(4):195-200.

PMID: 3548648 DOI: 10.1007/BF00290537.

[Detection of nephrotoxicity of human alpha 2b interferon with special reference to the analysis of urine enzymes in patients with chronic myeloid leukemia].

Kurschel E, Hofmann W, Niederle N Klin Wochenschr. 1987; 65(14):667-72.

PMID: 3476805 DOI: 10.1007/BF01875502.

References

Sriskandan K, Garner P, Watkinson J, Gerlis L, TEE D . A phase 1 study of recombinant interferon-gamma given intravenously by portable mini-pump: a preliminary report. Int J Clin Pharmacol Res. 1984; 4(6):469-74. View